Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients

J Thromb Haemost. 2020 Aug;18(8):2073-2075. doi: 10.1111/jth.14902.

Authors

Francisco Sandro Menezes-Rodrigues¹, José Gustavo Padrão Tavares¹, Marcelo Pires de Oliveira², Rafael Guzella de Carvalho³, Paolo Ruggero Errante¹, Murched Omar Taha⁴, Djalma José Fagundes⁴, Afonso Caricati-Neto¹

Affiliations

¹ Autonomic and Cardiovascular Pharmacology Lab, Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
² School of Medicine, União Metropolitana para o Desenvolvimento da Educação e da Cultura (UNIME), Lauro de Freitas, Brazil.
³ Hospital São Paulo, EPM, UNIFESP, São Paulo, Brazil.
⁴ Department of Surgery, EPM, UNIFESP, São Paulo, Brazil.

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants
Betacoronavirus
COVID-19
Coronavirus Infections*
Coronavirus*
Heparin*
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2

Substances

Anticoagulants
Heparin